Details van artikel 542 van 588 gevonden artikelen
P.149The MYODA operational seamless clinical trial design phase I to III: a new approach for rare diseases to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of BIO101 (MAS activator) in paediatric patients with a genetically confirmed diagnosis of Duchenne muscular dystrophy
Titel:
P.149The MYODA operational seamless clinical trial design phase I to III: a new approach for rare diseases to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of BIO101 (MAS activator) in paediatric patients with a genetically confirmed diagnosis of Duchenne muscular dystrophy
Auteur:
Chabane, M. Dioh, W. Dilda, P. Lafont, R. Veillet, S. Voit, T. Agus, S.
Verschenen in:
Neuromuscular disorders
Paginering:
Jaargang 29 (2019) nr. S1 pagina's S92
Jaar:
2019
Inhoud:
Uitgever:
Published by Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 542 van 588 gevonden artikelen